FDA Inspection 1251609 — Children's Hospital of Philadelphia

Children's Hospital of Philadelphia — FEI 2571772

The FDA completed an inspection of Children's Hospital of Philadelphia on September 30, 2024 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 30, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Philadelphia, PA (United States)